NYU Conference 10-27-12

Index

Next Topic: Section 1: Neurosurgery


The CART Transcript was from the October 2012 NYU NF Conference discussion about NF2 issues, treatments and managements.

********
The text for this event was provided in a rough draft format. Communication Access Realtime Translation (CART) is provided in order to facilitate communication accessibility and may not be a totally verbatim record of the proceedings.
********

Section 1: Neurosurgery
Dr. John Golfinos, NYU
  1. Management of NF2
  2. Radiation
  3. NF Clinics

Section 2: Neurootology
Dr. Kevin Brown, NY Presbyterian
  1. What are Schwann cells?
  2. Invasion of Vestibular Schwannoma
  3. Hearing
  4. Determination Factors for Treatments
  5. Radiotherapy and Merlin
  6. Middle Fossa Approach
  7. Retrosigmoid Approach
  8. Hearing Preservation Surgery
  9. Translabyrinthine Approach
  10. Baha - Hearing Loss One Ear
  11. Cochlear Implant
  12. Auditory Brain stem Implants
  13. Conclusion

Section 3: Otology and Hearing
Dr. Sean McMenomey, NYU
  1. Hearing Options
  2. Baha
  3. Cochlear Implant
  4. Auditory Brain stem Implants
  5. Conclusion

Section 4: Audiology
Joe Montano, New York Presbyterian
  1. Understanding an Audiogram
  2. Hearing Loss / Communication Loss
  3. Amplification Options
  4. Communication Strategies - Speechreading and ASL
  5. Cued Speech
  6. Amplification Options
  7. Hearing Assistive Technology
  8. Loop
  9. FM System
  10. Telephone Devices
  11. Computer Technology
  12. Signal Alerting Technology
  13. Auditory Visual Training
  14. Communication Groups
  15. Conclusion
  16. Questions

Section 5: Clinical Trials
Dr. Matthias Karajannis, NYU
Amanda Merkelson, NYU
  • Part 1: Current Trials, Dr. Matthias Karajannis
    1. Anti-tumor Drugs
    2. Molecular Target Agents not Chemo
    3. Avastin
    4. Lapatinib and RAD 001
    5. Conclusion
  • Part 2: Trial Participation, Amanda Merkelson
  • Part 3: Questions, Dr. Matthias Karajannis and Amanda Merkelson

Section 6: Speakers by Titles and Hospitals

Next Topic: Section 1: Neurosurgery

What is NF2? | About Us | Treatment Options | Sitemap

Disclaimer: Neurofibromatosis Type 2 - Information and Services, www.nf2is.org, is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. - Read More

Copyright © 2008 - 2017